Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations

Stock Quote

NASDAQCRDF
$1.64
NASDAQCRDF
Open
$1.64
Change
$0.01 (0.61%)
Day's Range
$1.60 - $1.65
52-Week Range
$1.20 - $3.41
Volume
83.7K
Market Cap
$73.3M